miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells

American Journal of Translational Research

Volumn 8, Issue 7, 2016, Pages 3013-3022

  Li, Bai ^a   Ge, Liang ^a   Li, Minghe ^b   Wang, Lei ^a   Li, Zhihong ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Hospital of Stomatology Jilin University   (China)

Author keywords

Colorectal cancer; IGF1R; Invasion; miR 448; Proliferation

Indexed keywords

MICRORNA; MICRORNA 448; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MIDDLE AGED; MTT ASSAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING; WOUND HEALING;

EID: 84979868503     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
2. Haggar FA and Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22: 191-197.
3. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
4. Erhard F, Haas J, Lieber D, Malterer G, Jaskiewicz L, Zavolan M, Dolken L and Zimmer R. Widespread context dependency of microRNA-mediated regulation. Genome Res 2014; 24: 906-919.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Zhang B and Farwell MA. microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008; 12: 3-21.
7. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
8. Tong AW and Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 2008; 15: 341-355.
9. Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 293-302.
10. Amirkhah R, Schmitz U, Linnebacher M, Wolkenhauer O and Farazmand A. MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression. Genes Chromosomes Cancer 2015; 54: 129-141.
11. Tokarz P and Blasiak J. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol 2012; 59: 467-474.
12. Wu X, Tang H, Liu G, Wang H, Shu J and Sun F. miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10. Tumour Biol 2016; [Epub ahead of print].
13. Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT and Chao TY. Aberrant KDM5B expression promotes aggressive bre-ast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. BMC Cancer 2016; 16: 160.
14. Lv Y, Lei Y, Hu Y, Ding W, Zhang C and Fang C. miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12. Clin Transl Oncol 2015; 17: 903-909.
15. Zhu H, Zhou X, Ma C, Chang H, Li H, Liu F and Lu J. Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma. Cell Physiol Biochem 2015; 36: 487-498.
16. Li N, Zhao X, Wang L, Zhang S, Cui M and He J. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R. Tumour Biol 2016; 37: 7767-76.
17. Brahmkhatri VP, Prasanna C and Atreya HS. Insulin-like growth factor system in cancer: novel targeted therapies. Biomed Res Int 2015; 2015: 538019.
18. Li B, Xie Z and Li B. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3. Tumour Biol 2016; [Epub ahead of print].
19. Liang WL, Cao J, Xu B, Yang P, Shen F, Sun Z, Li WL, Wang Q and Liu F. miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells. Biomed Pharmacother 2015; 72: 119-124.
20. Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q and Liu J. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 2012; 84: 320-330.
21. Liu R, Hu LL, Sun A, Cao YJ, Tang T, Zhang XP and Zhang QH. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes. Arch Med Res 2014; 45: 318-324.
22. Knowlden JM, Jones HE, Barrow D, Gee JM, Nicholson RI and Hutcheson IR. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance. Breast Cancer Res Treat 2008; 111: 79-91.
23. Davies M, Gupta S, Goldspink G and Winslet M. The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence. Int J Colorectal Dis 2006; 21: 201-208.
24. Vanamala J, Reddivari L, Radhakrishnan S and Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 2010; 10: 238.
25. Hassan AB and Macaulay VM. The insulin-like growth factor system as a therapeutic target in colorectal cancer. Ann Oncol 2002; 13: 349-356.
26. Zhang QY, Wang L, Song ZY and Qu XJ. Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/beta-catenin signal pathways. Biomed Pharmacother 2015; 73: 12-18.